Immunotech Laboratories, Inc. (OTCMARKETS:IMMB) Immunotech Laboratories,
Inc. announced today that the Phase I and Phase II field trials in
Bulgaria of the Company’s HIV/AIDS and Hepatitis C virus treatment
(“ITV-1 Treatment”) have been successfully completed.
for Immunotech Laboratories, Inc. Announces Successful Completion of Phase I and Phase II Field Trials of the Company’s Patented Treatment of the HIV/AIDS and Hepatitis C Viruses investment picks